hyoscyamine sulfate 0.125 MG Disintegrating Oral Tablet
RxNorm concept 1046985, clinical drug (scd).
- RxCUI
- 1046985
- Term type
- Clinical drug (SCD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/1046985 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Related concepts
- hyoscyamine sulfate 0.125 MG (SCDC, consists of)
- Disintegrating Oral Tablet (DF, has dose form)
- hyoscyamine sulfate 0.125 MG Disintegrating Oral Tablet [Symax] (SBD, has tradename)
- hyoscyamine sulfate 0.125 MG Disintegrating Oral Tablet [Anaspaz] (SBD, has tradename)
- hyoscyamine sulfate 0.125 MG Disintegrating Oral Tablet [Ed Spaz] (SBD, has tradename)
- hyoscyamine sulfate 0.125 MG Disintegrating Oral Tablet [Oscimin] (SBD, has tradename)
- hyoscyamine sulfate 0.125 MG Disintegrating Oral Tablet [Nulev] (SBD, has tradename)
Linked data
NDCs
- 00574024701
- 10135018401
- 39328004910
- 42192033801
- 42192033805
- 43199001201
- 47781001201
- 57629020210
- 62135085812
- 62559042201
- 63561019701
- 63629103001
- 69367067901
- 70156010601
- 71186000725
- 72162194101
- 72789056301
- 76439030710
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 1046985 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/1046985 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 1046985. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.